BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16731022)

  • 1. Pisa syndrome as a motor complication of Parkinson's disease.
    Kim JS; Park JW; Chung SW; Kim YI; Kim HT; Lee KS
    Parkinsonism Relat Disord; 2007 Mar; 13(2):126-8. PubMed ID: 16731022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dystonia in Parkinson's disease: clinical and pharmacological features.
    Poewe WH; Lees AJ; Stern GM
    Ann Neurol; 1988 Jan; 23(1):73-8. PubMed ID: 3345068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of levodopa-responsive camptocormia associated with advanced Parkinson's disease.
    Ho B; Prakash R; Morgan JC; Sethi KD
    Nat Clin Pract Neurol; 2007 Sep; 3(9):526-30. PubMed ID: 17805247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pain intensity on and off levodopa in patients with Parkinson's disease.
    Nebe A; Ebersbach G
    Mov Disord; 2009 Jun; 24(8):1233-7. PubMed ID: 19412949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower limb post-immobilization dystonia in Parkinson's disease.
    Singer C; Papapetropoulos S
    J Neurol Sci; 2005 Dec; 239(1):111-4. PubMed ID: 16182312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pisa syndrome without neuroleptic exposure in a patient with Parkinson's disease: case report.
    Gambarin M; Antonini A; Moretto G; Bovi P; Romito S; Fiaschi A; Tinazzi M
    Mov Disord; 2006 Feb; 21(2):270-3. PubMed ID: 16161148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography.
    Dhawan V; Dhoat S; Williams AJ; Dimarco A; Pal S; Forbes A; Tobías A; Martinez-Martin P; Chaudhuri KR
    J Neurol Sci; 2006 Oct; 248(1-2):158-62. PubMed ID: 16780888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reoperation for suboptimal outcomes after deep brain stimulation surgery.
    Ellis TM; Foote KD; Fernandez HH; Sudhyadhom A; Rodriguez RL; Zeilman P; Jacobson CE; Okun MS
    Neurosurgery; 2008 Oct; 63(4):754-60; discussion 760-1. PubMed ID: 18981887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
    Yamada K; Goto S; Hamasaki T; Kuratsu JI
    Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management for motor and non-motor complications in late Parkinson's disease.
    Chan DK; Cordato DJ; O'Rourke F
    Geriatrics; 2008 May; 63(5):22-7. PubMed ID: 18447408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metatarsal fracture as a consequence of foot dystonia in Parkinson's disease.
    McDade E; Weiner WJ; Shulman LM
    Parkinsonism Relat Disord; 2008; 14(4):353-5. PubMed ID: 18457984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Deep brain stimulation for Parkinson's disease and dystonia].
    Yokochi F
    Brain Nerve; 2009 Apr; 61(4):473-83. PubMed ID: 19378817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation.
    Ardouin C; Voon V; Worbe Y; Abouazar N; Czernecki V; Hosseini H; Pelissolo A; Moro E; Lhommée E; Lang AE; Agid Y; Benabid AL; Pollak P; Mallet L; Krack P
    Mov Disord; 2006 Nov; 21(11):1941-6. PubMed ID: 16972268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors in development of motor complications in Chinese patients with idiopathic Parkinson's disease.
    Kum WF; Gao J; Durairajan SS; Man SC; Xie LX; Lu JH; Fong WL; Li M
    J Clin Neurosci; 2009 Aug; 16(8):1034-7. PubMed ID: 19428256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
    Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI
    Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Motor fluctuations and dyskinesias in Parkinson's disease: variables that discriminate both complications in a sample of 285 patients].
    Gómez JC; Rouco I; Velasco F; Tijero B; Garamendi I; Lezcano E; Zarranz JJ
    Neurologia; 2008 Oct; 23(8):494-8. PubMed ID: 18770057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factors associated with the development of motor complications in Parkinson's disease. A study in a Chilean population].
    Juri-Claveria C; Aguirre-M C; Viviani-G P; Chana-Cuevas P
    Rev Neurol; 2007 Jul 16-31; 45(2):77-80. PubMed ID: 17642046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levodopa induced motor complications in Thai Parkinson's disease patients.
    Kulkantrakorn K; Tiamkao S; Pongchaiyakul C; Pulkes T
    J Med Assoc Thai; 2006 May; 89(5):632-7. PubMed ID: 16756048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motor fluctuations in Parkinson's disease.
    Weiner WJ
    Rev Neurol Dis; 2006; 3(3):101-8. PubMed ID: 17047575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.